Bristol Myers Squibb to Participate in Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Bristol-Myers Squibb Co. (BMY) PT Raised to $51 at Jefferies
August 28, 2024 5:41 AM EDTJefferies analyst Akash Tewari raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $51.00 (from $49.00) while maintaining a Hold rating.
The analyst comments "Bayer will present asundexian OCEANIC-AF data at ESC (stopped due to inferior efficacy vs Eliquis). While we remain on... More
